FBIO (Fortress Biotech, Inc.)
Insider Trading Activity
Every open-market purchase and sale reported by FBIO officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-24 | David Jin | Chief Financial Officer | A | — | — |
| 2017-11-08 | LINDSAY A MD ROSENWALD | PRESIDENT, CEO | Buy | — | — |
| 2017-07-21 | Dov Klein | Director | D | — | — |
| 2017-07-21 | Malcolm Hoenlein | Director | A | — | — |
| 2017-07-21 | Jimmie Harvey | Director | A | — | — |
| 2017-01-27 | MICHAEL S WEISS | Exec. VC - Strategic Dev. | A | — | — |
| 2017-01-27 | LINDSAY A MD ROSENWALD | President and CEO | MIXED | — | — |
| 2017-01-24 | Malcolm Hoenlein | Director | A | — | — |
| 2017-01-24 | Jimmie Harvey | Director | A | — | — |
| 2017-01-24 | Eric K Rowinsky | Director | A | — | — |
| 2017-01-24 | Dov Klein | Director | MIXED | — | — |
| 2017-01-24 | J JAY LOBELL | Director | A | — | — |
| 2016-09-19 | George Avgerinos | SVP, Biologics Operations | Sell | — | — |
| 2016-09-16 | George Avgerinos | SVP, Biologics Operations | A | — | — |
| 2016-07-19 | Dov Klein | Director | D | — | — |
| 2016-06-17 | LINDSAY A MD ROSENWALD | President and CEO | Buy | — | — |
| 2016-03-28 | Jimmie Harvey | Director | A | — | — |
| 2016-03-28 | Malcolm Hoenlein | Director | A | — | — |
| 2016-01-05 | MICHAEL S WEISS | Exec. VC - Strategic Dev. | A | — | — |
| 2016-01-05 | Eric K Rowinsky | Director | A | — | — |
| 2016-01-05 | Dov Klein | Director | A | — | — |
| 2016-01-05 | J JAY LOBELL | Director | A | — | — |
| 2016-01-05 | LINDSAY A MD ROSENWALD | President and CEO | A | — | — |
| 2015-12-09 | LINDSAY A MD ROSENWALD | President and CEO | Buy | — | — |
| 2015-09-14 | George Avgerinos | SVP, Biologics Operations | D | — | — |
| 2015-09-10 | George Avgerinos | SVP, Biologics Operations | D | — | — |
| 2015-09-08 | George Avgerinos | SVP, Biologics Operations | D | — | — |
| 2015-09-04 | George Avgerinos | SVP, Biologics Operations | D | — | — |
| 2015-09-03 | George Avgerinos | SVP, Biologics Operations | D | — | — |
| 2015-09-02 | George Avgerinos | SVP, Biologics Operations | D | — | — |
| 2015-08-25 | George Avgerinos | SVP, Biologics Operations | D | — | — |
| 2015-08-21 | George Avgerinos | SVP, Biologics Operations | D | — | — |
| 2015-08-14 | George Avgerinos | SVP, Biologics Operations | A | — | — |
| 2015-07-17 | George Avgerinos | SVP, Biologics Operations | D | — | — |
| 2015-07-17 | Dov Klein | Director | A | — | — |
| 2015-06-03 | LINDSAY A MD ROSENWALD | President and CEO | Buy | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Chief Financial Officer | 1,651,571 | — |
| — | Exec. VC - Strategic Dev. | 533,411 | — |
| — | Director | 45,733 | — |
| — | Director | 23,333 | — |
| — | SVP, Biologics Operations | 19,533 | — |
| — | Director | 13,565 | — |
| — | PRESIDENT, CEO | 8,000 | — |
| — | Director | 3,667 | — |
| — | Director | 3,333 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the FBIO quote page; the site-wide leaderboard is on the insider transactions hub.